{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T05:00:40Z","timestamp":1693112440750},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1007\/s00108-007-1827-8","type":"journal-article","created":{"date-parts":[[2007,3,29]],"date-time":"2007-03-29T11:11:33Z","timestamp":1175166693000},"page":"497-506","source":"Crossref","is-referenced-by-count":8,"title":["Interferon-\u03b3-Release-Assays in der Tuberkulosediagnostik"],"prefix":"10.1007","volume":"48","author":[{"given":"H.","family":"Hoffmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Loytved","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Bodmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1827_CR1","first-page":"19","volume":"44","author":"Anonymous","year":"1995","unstructured":"Anonymous (1995) Screening for tuberculosis and tuberculosis infection in high-risk populations. Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Recomm Rep 44: 19\u201334","journal-title":"MMWR Recomm Rep"},{"key":"1827_CR2","first-page":"1","volume":"49","author":"Anonymous","year":"2000","unstructured":"Anonymous (2000) American Thoracic Society: Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep 49: 1\u201351","journal-title":"MMWR Recomm Rep"},{"key":"1827_CR3","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1164\/ajrccm.161.supplement_3.ats600","volume":"161","author":"Anonymous","year":"2000","unstructured":"Anonymous (2000) Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med 161: S221\u2013S247","journal-title":"Am J Respir Crit Care Med"},{"key":"1827_CR4","doi-asserted-by":"crossref","unstructured":"Arend SM, Thijsen SF, Leyten EM et al. (2006) Comparison of two interferon-gamma assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med; Epub ahead of print","DOI":"10.1164\/rccm.200608-1099OC"},{"key":"1827_CR5","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1164\/rccm.200607-907ED","volume":"174","author":"Barnes","year":"2006","unstructured":"Barnes PF (2006) Weighing gold or counting spots: which is more sensitive to diagnose latent tuberculosis infection? Am J Respir Crit Care Med 174: 731\u2013732","journal-title":"Am J Respir Crit Care Med"},{"key":"1827_CR6","unstructured":"Berufsgenossenschaften (Hrsg) (1998) Arbeitsmedizinische Vorsorge. Berufsgenossenschaftliche Grunds\u00e4tze f\u00fcr arbeitsmedizinische Vorsorgeuntersuchungen (2. Aufl.). Gentner, Stuttgart"},{"key":"1827_CR7","first-page":"50","volume":"I","author":"Biostoffverordnung","year":"1999","unstructured":"Biostoffverordnung (1999) Verordnung zur Umsetzung von EG-Richtlinien \u00fcber den Schutz der Besch\u00e4ftigten gegen Gef\u00e4hrdung durch biologische Arbeitsstoffe bei der Arbeit (BioStoffV) vom 27.01.1999. Bundesgesetzblatt I: 50\u201360","journal-title":"Bundesgesetzblatt"},{"key":"1827_CR8","doi-asserted-by":"crossref","unstructured":"Britton WJ, Gilbert GL, Wheatley J et al. (2005) Sensitivity of human gamma interferon assay and tuberculin skin testing for detecting infection with Mycobacterium tuberculosis in patients with culture positive tuberculosis. Tuberculosis (Edinb) 85: 137\u2013145","DOI":"10.1016\/j.tube.2004.06.003"},{"key":"1827_CR9","unstructured":"Brodhun B, Gronauer W, Haas W et al. (2005) Empfehlungen zur Tuberkulose-Umgebungsuntersuchung f\u00fcr die Gesundheits\u00e4mter Bayerns. 1. Bayerisches Landesamt f\u00fcr Gesundheit und Lebensmittelsicherheit, Erlangen, http:\/\/www.lgl.bayern.de"},{"key":"1827_CR10","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.tim.2004.09.007","volume":"12","author":"Brodin","year":"2004","unstructured":"Brodin P, Rosenkrands I, Andersen P et al. (2004) ESAT-6 proteins: protective antigens and virulence factors? Trends Microbiol 12: 500\u2013508","journal-title":"Trends Microbiol"},{"key":"1827_CR11","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1073\/pnas.052548299","volume":"99","author":"Brosch","year":"2002","unstructured":"Brosch R, Gordon SV, Marmiesse M et al. (2002) A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci USA 99: 3684\u20133689","journal-title":"Proc Natl Acad Sci USA"},{"key":"1827_CR12","unstructured":"Burmester G-R, Detert J (2003) Neue Therapien in der Behandlung der rheumatoiden Arthritis. Arztinformation Oktober\/Dezember 2003. http:\/\/www.dgrh.de\/572.html"},{"key":"1827_CR13","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/00002030-200211220-00008","volume":"16","author":"Chapman","year":"2002","unstructured":"Chapman AL, Munkanta M, Wilkinson KA et al. (2002) Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS 16: 2285\u20132293","journal-title":"AIDS"},{"key":"1827_CR14","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1055\/s-2002-36124","volume":"56","author":"Dalhoff","year":"2002","unstructured":"Dalhoff K, Ewig S, Hoffken G et al. (2002) [Recommendations for the diagnosis, therapy and prevention of pneumonia in the immunocompromised host]. Pneumologie 56: 807\u2013831","journal-title":"Pneumologie"},{"key":"1827_CR15","unstructured":"Deutsches Zentralkomitee zur Bek\u00e4mpfung der Tuberkulose (1996) Richtlinien zur Tuberkulindiagnostik. Dtsch \u00c4rztebl 93\/18: 1199\u20131201"},{"key":"1827_CR16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1086\/509928","volume":"44","author":"Dewan","year":"2007","unstructured":"Dewan PK, Grinsdale J, Kawamura LM (2007) Low sensitivity of a whole-blood interferon-gamma release assay for detection of active tuberculosis. Clin Infect Dis 44: 69\u201373","journal-title":"Clin Infect Dis"},{"key":"1827_CR17","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1097\/01.aids.0000191923.08938.5b","volume":"19","author":"Dheda","year":"2005","unstructured":"Dheda K, Lalvani A, Miller RF et al. (2005) Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count. AIDS 19: 2038\u20132041","journal-title":"AIDS"},{"key":"1827_CR18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1183\/09031936.06.00011806","volume":"28","author":"Diel","year":"2006","unstructured":"Diel R, Nienhaus A, Lange C et al. (2006) Cost optimization of screening for latent tuberculosis in close contacts. Eur Respir J 28: 35\u201344","journal-title":"Eur Respir J"},{"key":"1827_CR19","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/S0140-6736(03)12950-9","volume":"361","author":"Ewer","year":"2003","unstructured":"Ewer K, Deeks J, Alvarez L et al. (2003) Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 361: 1168\u20131173","journal-title":"Lancet"},{"key":"1827_CR20","first-page":"1034","volume":"9","author":"Ferrand","year":"2005","unstructured":"Ferrand RA, Bothamley GH, Whelan A et al. (2005) Interferon-gamma responses to ESAT-6 in tuberculosis patients early into and after anti-tuberculosis treatment. Int J Tuberc Lung Dis 9: 1034\u20131039","journal-title":"Int J Tuberc Lung Dis"},{"key":"1827_CR21","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0140-6736(06)68579-6","volume":"367","author":"Ferrara","year":"2006","unstructured":"Ferrara G, Losi M, D\u2019Amico R et al. (2006) Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 367: 1328\u20131334","journal-title":"Lancet"},{"key":"1827_CR22","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1469-0691.2006.01391.x","volume":"12","author":"Goletti","year":"2006","unstructured":"Goletti D, Carrara S, Vincenti D et al. (2006) Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study. Clin Microbiol Infect 12: 544\u2013550","journal-title":"Clin Microbiol Infect"},{"key":"1827_CR23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10405-006-0102-3","volume":"3","author":"Hauer","year":"2006","unstructured":"Hauer B (2006) Diagnostik der Tuberkuloseinfektion: Tuberkulintest und Gamma-Interferontest. Pneumologe 3: 277\u2013286","journal-title":"Pneumologe"},{"key":"1827_CR24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1055\/s-2005-919075","volume":"60","author":"Hauer","year":"2006","unstructured":"Hauer B, Loddenkemper R, Detjen A et al. (2006) [Interferon-gamma assays \u2013 description and assessment of a new tool in the diagnosis of tuberculosis]. Pneumologie 60: 29\u201344","journal-title":"Pneumologie"},{"key":"1827_CR25","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1086\/382362","volume":"38","author":"Hill","year":"2004","unstructured":"Hill PC, Brookes RH, Fox A et al. (2004) Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin Infect Dis 38: 966\u2013973","journal-title":"Clin Infect Dis"},{"key":"1827_CR26","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1128\/CDLI.6.6.934-937.1999","volume":"6","author":"Johnson","year":"1999","unstructured":"Johnson PD, Stuart RL, Grayson ML et al. (1999) Tuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis. Clin Diagn Lab Immunol 6: 934\u2013937","journal-title":"Clin Diagn Lab Immunol"},{"key":"1827_CR27","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1001\/jama.293.22.2756","volume":"293","author":"Kang","year":"2005","unstructured":"Kang YA, Lee HW, Yoon HI et al. (2005) Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 293: 2756\u20132761","journal-title":"JAMA"},{"key":"1827_CR28","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","volume":"345","author":"Keane","year":"2001","unstructured":"Keane J, Gershon S, Wise RP et al. (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345: 1098\u20131104","journal-title":"N Engl J Med"},{"key":"1827_CR29","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1086\/509327","volume":"43","author":"Kobashi","year":"2006","unstructured":"Kobashi Y, Obase Y, Fukuda M et al. (2006) Clinical reevaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from nontuberculous mycobacteriosis. Clin Infect Dis 43: 1540\u20131546","journal-title":"Clin Infect Dis"},{"key":"1827_CR30","unstructured":"Kollecker S (2003) Zur Frage der Anzeigepflicht von \u00c4rzten bei Tuberkulinkonversion. In: Nienhaus A, Brandenburg S, Teschler H (Hrsg) Tuberkulose als Berufskrankheit. Ein Leitfaden zur Begutachtung. ecomed, Landsberg, S\u00a068\u201370"},{"key":"1827_CR31","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/S0140-6736(00)05115-1","volume":"357","author":"Lalvani","year":"2001","unstructured":"Lalvani A, Pathan AA, Durkan H et al. (2001) Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 357: 2017\u20132021","journal-title":"Lancet"},{"key":"1827_CR32","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1164\/ajrccm.163.4.2009100","volume":"163","author":"Lalvani","year":"2001","unstructured":"Lalvani A, Pathan AA, McShane H et al. (2001) Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med 163: 824\u2013828","journal-title":"Am J Respir Crit Care Med"},{"key":"1827_CR33","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/S0140-6736(04)17592-2","volume":"364","author":"Liebeschuetz","year":"2004","unstructured":"Liebeschuetz S, Bamber S, Ewer K et al. (2004) Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 364: 2196\u20132203","journal-title":"Lancet"},{"key":"1827_CR34","first-page":"49","volume":"54","author":"Mazurek","year":"2005","unstructured":"Mazurek GH, Jereb J, Lobue P et al. (2005) Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 54: 49\u201355","journal-title":"MMWR Recomm Rep"},{"key":"1827_CR35","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10096-005-1377-8","volume":"24","author":"Meier","year":"2005","unstructured":"Meier T, Eulenbruch HP, Wrighton-Smith P et al. (2005) Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur J Clin Microbiol Infect Dis 24: 529\u2013536","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1827_CR36","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1086\/421494","volume":"39","author":"Mohan","year":"2004","unstructured":"Mohan AK, Cote TR, Block JA et al. (2004) Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor. Clin Infect Dis 39: 295\u2013299","journal-title":"Clin Infect Dis"},{"key":"1827_CR37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200402-179OC","volume":"170","author":"Mori","year":"2004","unstructured":"Mori T, Sakatani M, Yamagishi F et al. (2004) Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 170: 59\u201364","journal-title":"Am J Respir Crit Care Med"},{"key":"1827_CR38","unstructured":"NICE (Ed) (2006) Tuberculosis. Clinical diagnosis and management of tuberculosis, and measures for its prevention and control. Royal College of Physicians, London"},{"key":"1827_CR39","unstructured":"Nienhaus A, Rem\u00e9 T (2003) Zur Frage der Anzeigepflicht von \u00c4rzten bei Tuberkulinkonversion. In: Nienhaus A, Brandenburg S, Teschler H (Hrsg) Tuberkulose als Berufskrankheit. Ein Leitfaden zur Begutachtung. ecomed, Landsberg, S\u00a0174\u2013178"},{"key":"1827_CR40","unstructured":"Nienhaus A, Loddenkemper R, Hauer B et al. (in press) Tuberkuloseinfektion im Gesundheitswesen \u2013 Evaluation des Interferon-gamma Release Assays. Pneumologie"},{"key":"1827_CR41","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S1473-3099(04)01206-X","volume":"4","author":"Pai","year":"2004","unstructured":"Pai M, Riley LW, Colford JMJ (2004) Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 4: 761\u2013776","journal-title":"Lancet Infect Dis"},{"key":"1827_CR42","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1001\/jama.293.22.2746","volume":"293","author":"Pai","year":"2005","unstructured":"Pai M, Gokhale K, Joshi R et al. (2005) Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA 293: 2746\u20132755","journal-title":"JAMA"},{"key":"1827_CR43","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1586\/14737159.6.3.413","volume":"6","author":"Pai","year":"2006","unstructured":"Pai M, Kalantri S, Dheda K (2006) New tools and emerging technologies for the diagnosis of tuberculosis. Part I: Latent tuberculosis. Expert Rev Mol Diagn 6: 413\u2013422","journal-title":"Expert Rev Mol Diagn"},{"key":"1827_CR44","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1164\/ajrccm.173.1.130","volume":"173","author":"Piana","year":"2006","unstructured":"Piana F, Codecasa LR, Besozzi G et al. (2006) Use of commercial interferon-gamma assays in immunocompromised patients for tuberculosis diagnosis. Am J Respir Crit Care Med 173: 130; author reply 130\u2013131","journal-title":"Am J Respir Crit Care Med"},{"key":"1827_CR45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1183\/09031936.06.00110205","volume":"28","author":"Piana","year":"2006","unstructured":"Piana F, Codecasa LR, Cavallerio P et al. (2006) Use of a T-cell based test for detection of TB infection among immunocompromised patients. Eur Respir J 28: 31\u201334","journal-title":"Eur Respir J"},{"key":"1827_CR46","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1164\/rccm.200403-307OC","volume":"170","author":"Richeldi","year":"2004","unstructured":"Richeldi L, Ewer K, Losi M et al. (2004) T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure. Am J Respir Crit Care Med 170: 288\u2013295","journal-title":"Am J Respir Crit Care Med"},{"key":"1827_CR47","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/rccm.200509-1516PP","volume":"174","author":"Richeldi","year":"2006","unstructured":"Richeldi L (2006) An update on the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 174: 736\u2013742","journal-title":"Am J Respir Crit Care Med"},{"key":"1827_CR48","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1055\/s-2004-818448","volume":"58","author":"Schaberg","year":"2004","unstructured":"Schaberg T, Hauer B, Haas WH et al. (2004) [Latent tuberculosis infection: recommendations for preventive therapy in adults in Germany]. Pneumologie 58: 255\u2013270","journal-title":"Pneumologie"},{"key":"1827_CR49","unstructured":"Schablon A, Diel R, Beckmann G et al. (2006) Evaluation des Tbc-Bluttests in der betrieblichen Praxis. http:\/\/www.bgw-online.de"},{"key":"1827_CR50","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1164\/rccm.200505-748OC","volume":"172","author":"Shams","year":"2005","unstructured":"Shams H, Weis SE, Klucar P et al. (2005) Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection. Am J Respir Crit Care Med 172: 1161\u20131168","journal-title":"Am J Respir Crit Care Med"},{"key":"1827_CR51","first-page":"555","volume":"4","author":"Stuart","year":"2000","unstructured":"Stuart RL, Olden D, Johnson PD et al. (2000) Effect of anti-tuberculosis treatment on the tuberculin interferon-gamma response in tuberculin skin test (TST) positive health care workers and patients with tuberculosis. Int J Tuberc Lung Dis 4: 555\u2013561","journal-title":"Int J Tuberc Lung Dis"},{"key":"1827_CR52","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/thorax.57.9.804","volume":"57","author":"Wang","year":"2002","unstructured":"Wang L, Turner MO, Elwood RK et al. (2002) A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurements. Thorax 57: 804\u2013809","journal-title":"Thorax"},{"key":"1827_CR53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1183\/09031936.06.00005906","volume":"28","author":"Wrighton-Smith","year":"2006","unstructured":"Wrighton-Smith P, Zellweger JP (2006) Direct costs of three models for the screening of latent tuberculosis infection. Eur Respir J 28: 45\u201350","journal-title":"Eur Respir J"},{"key":"1827_CR54","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1164\/rccm.2512002","volume":"173","author":"Yew","year":"2006","unstructured":"Yew WW, Leung CC (2006) Update in tuberculosis 2005. Am J Respir Crit Care Med 173: 491\u2013498","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-007-1827-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-007-1827-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-007-1827-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T23:31:24Z","timestamp":1587425484000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-007-1827-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["1827"],"URL":"https:\/\/doi.org\/10.1007\/s00108-007-1827-8","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}